LNWH medicines programme delivers more than £5.3m in savings

A medicines management programme run by London North West University Healthcare NHS Trust has been shortlisted for the national Health Service Journal Awards 2026. The trust, which operates Ealing Hospital, says the initiative has so far delivered more than £5.3 million in improvement and efficiency savings.

The Medicines Management Transformation Programme was introduced in 2023. Its purpose was to bring previously separate activity into one clinically led, data-driven programme. Pharmacy, finance and clinical teams share responsibility for its results. According to LNWH, this structure makes it easier to compare practice, identify unwarranted variation and make decisions that take account of both treatment and cost.

The programme is a finalist in the Medicines, Pharmacy and Prescribing Initiative of the Year category. Being shortlisted does not mean that LNWH has won the award. It is, however, external recognition for an approach the trust presents as a more consistent way to manage medicines across several sites, including Ealing Hospital.

LNWH lists four main achievements: reducing unwarranted variation, improving patient experience, supporting medicines optimisation and contributing to the NHS Net Zero agenda. These results come from the trust's own announcement. The statement does not provide a detailed breakdown of the £5.3 million figure by hospital or by individual measure. The full amount should therefore not be read as a saving attributed only to Ealing Hospital.

For patients in Ealing, the local significance is that the programme is being used by the organisation responsible for their hospital. Medicines management covers more than purchasing. It also includes choosing treatments, monitoring how medicines are used and reducing unnecessary differences between clinical teams. LNWH stresses that the purpose is not simply to cut spending, but to create a model intended to support patient outcomes and lasting value across the health system.

At this stage, the announcement concerns the nomination and the programme's reported results. It does not give a date for the award decision or announce any new instructions for patients. People using Ealing Hospital do not need to take any action. The nomination is chiefly a test of whether the trust's combination of clinical leadership, data and financial oversight is judged to be a strong model for medicines management.

The trust also says the work depended on collaboration beyond the pharmacy department. Finance, clinical services, procurement, operational teams and wider north-west London partners were involved. Pharmacist Aarti Patel described the recognition as the result of a genuine team effort. That structure is central to the programme: responsibility for the use and cost of medicines is shared by people making both clinical and organisational decisions.